Cabometyx
Cabometyx (pronounced: ka-bo-ME-tiks) is a brand name for the drug cabozantinib, which is used to treat various types of cancer, including renal cell carcinoma and hepatocellular carcinoma.
Etymology
The name "Cabometyx" is a combination of the generic name "cabozantinib" and the suffix "-tyx", which is commonly used in pharmaceutical branding. The "cabo-" prefix is derived from the chemical structure of the drug, which contains a carboxamide group.
Usage
Cabometyx is used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, and hepatocellular carcinoma (HCC), a type of liver cancer. It is typically used when the cancer has spread to other parts of the body. Cabometyx works by blocking the action of certain proteins that signal cancer cells to grow and divide.
Related Terms
- Cabozantinib: The generic name for Cabometyx.
- Renal cell carcinoma: A type of kidney cancer that Cabometyx is used to treat.
- Hepatocellular carcinoma: A type of liver cancer that Cabometyx is used to treat.
See Also
External links
- Medical encyclopedia article on Cabometyx
- Wikipedia's article - Cabometyx
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski